Chinese medical AI beats 250 top doctors 88-12 on complex lung cancer cases in new study
量子位 · wechat · 2026-11-13
MedGPT, by Chinese AI healthcare firm Future Doctor, outperformed 250 physicians from top-tier hospitals 88-12 on 40 complex 'gray-zone' lung cancer cases under a blind, rule-frozen AI-judged evaluation. Doctor scores rose 24.1% with MedGPT assistance, and it beat GPT-5.4, Claude Opus 4.7 and Gemini 3.1 Pro head-to-head (96.22 vs 71.38/61.81/54.62). The system uses multi-specialty agents, a 201k-entry clinical evidence unit library, and world-model simulation to generate multi-path treatment strategies. It is China's first approved generative AI model for diagnosis and treatment advice.
Related event: Medical AI Beats Top Hospital Doctors 88-12 in Lung Cancer Study(2 posts)→
More from Models
- DeepMind unveils Gemini Robotics 2.5: robots tie bows autonomously, 96% pick-and-pack success at Mercedes-Benz — AI_Andrew · 2026-11-13
- Unverified claims: OpenAI's Astra 6 held back by misalignment, Astra 6.1 reportedly cancelled — haider1 · 2026-11-13
- Claude Fable 5.2's 950K-Character System Prompt Leaked: 128 Tools, Hidden Mythos Tier Exposed — 新智元 · 2026-11-13
- LatentSpace's first model review: Naive-N0.5-Flash beats DeepSeek on coding, hits 2100 tokens/s — 量子位 · 2026-11-13
- Artificial Analysis Scores Qwen3.8-Flash-Next at 29, Between GPT-6 Luna Max and Haiku 5.5 — lionellee77 · 2026-11-13
- User finds Claude Opus 5.5 more creative and intuitive than Fable 5.2 — RileyRalmuto · 2026-11-13